QIAGEN Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years
Project
QCI is a powerful, high quality decision support solution for rapid interpretation of hereditary
diseases
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced that Genomics England have selected QIAGEN’s QCI (QIAGEN
Clinical Insights) portfolio offering on behalf of the NHS in England to support the UK’s program to sequence, analysis and
interpret 5 million genomes over the next 5 years.
QCI’s leading position as a decision support tool for personalized, precision medicine is based on its powerful capabilities to
simultaneously mine a large number of proprietary and public knowledge and data bases, many of which are expertly curated, to
provide accurate and up-to-date interpretations of complex genomic data. A pivotal knowledge base for this project was QIAGEN’s
proprietary HGMD® Human Gene Mutation Database offering, which is one of the key interpretation resources of QCI
and offers the most comprehensive and highly curated survey of literature-based genetic mutations responsible for human inherited
diseases.
Under the terms of the agreement with Genomics England on behalf of the NHS, QIAGEN will support a national network of UK
laboratories that are providing all genetic testing for National Health Service (NHS) patients across the country.
Of more than 4,000 known genetic disorders, some are apparent at birth while others do not surface until later in childhood or
even adulthood. The nonprofit Genetic Disorders UK estimates that each year 30,000 babies and children in the United Kingdom – one
in 25 children – are affected by a genetic disorder.
Please find the full press release
here.
QIAGEN
Investor Relations
John Gilardi +49 2103 29 11711
Sarah Fakih +49 2103 29 11457
e-mail: ir@QIAGEN.com
Public Relations
Thomas Theuringer +49 2103 29 11826
Robert Reitze +49 2103 29 11676
e-mail: pr@QIAGEN.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190203005036/en/